Life sciences software startup Benchling files for U.S. listing -sources_老虎社区_美港股上老虎

Life sciences software startup Benchling files for U.S. listing -sources

Reuters2021-11-18

Benchling, which develops software tools for scientists and pharmaceutical research organizations, has confidentially submitted paperwork with regulators for a stock market listing in New York, ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

OnlyPro
·2021-11-18
[害羞]
回复
3
举报
收起
- 股神徒孙:
  Okay
  2021-11-18
  回复
  举报
- OnlyPro:
  h
  2021-11-18
  回复
  举报
Tinktink
·2021-11-18
Thanks
回复
4
举报
我已经戒赌股票了相信我
·2021-11-18
Ok
回复
2
举报
UnknownTD
·2021-11-18
pls like
回复
2
举报
收起
- granola:
  Okay!
  2021-11-18
  回复
  举报
Syee
·2021-11-18
Like
回复
2
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1196614874?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-11-18 19:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1196614874","market":"us","top_or_hot":-1,"title":"Life sciences software startup Benchling files for U.S. listing -sources","media":"Reuters","content":"<div>\n<p>Benchling, which develops software tools for scientists and pharmaceutical research organizations, has confidentially submitted paperwork with regulators for a stock market listing in New York, ...</p>\n\n<a href=\"https://finance.yahoo.com/news/life-sciences-software-startup-benchling-110000545.html\">网页链接</a>\n\n</div>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Life sciences software startup Benchling files for U.S. listing -sources</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLife sciences software startup Benchling files for U.S. listing -sources\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-18 19:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/life-sciences-software-startup-benchling-110000545.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Benchling, which develops software tools for scientists and pharmaceutical research organizations, has confidentially submitted paperwork with regulators for a stock market listing in New York, ...</p>\n\n<a href=\"https://finance.yahoo.com/news/life-sciences-software-startup-benchling-110000545.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://finance.yahoo.com/news/life-sciences-software-startup-benchling-110000545.html","article_id":"1196614874","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1196614874","pubTimestamp":1637234017,"columns":[],"sourceInfo":null,"weMediaInfo":null,"summary":"Benchling, which develops software tools for scientists and pharmaceutical research organizations, h","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"美国上市的生命科学软件初创企业基准文件-来源","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{},"content_text":"Benchling, which develops software tools for scientists and pharmaceutical research organizations, has confidentially submitted paperwork with regulators for a stock market listing in New York, according to people familiar with the matter.\nThe San Francisco, California-based company, which was valued at $4 billion in a funding round earlier this year, is aiming to go public in early 2022 at a much higher valuation, the sources said.\nBenchling is considering going public through a direct listing, although the company has not ruled out a traditional IPO (initial public offering), sources said. One of its major investors on the board, Benchmark Capital, has been a vocal advocate of direct listings.\nThe start-up hired investment banks and other financial advisors earlier this year to advise on its listing plans, the sources said.\nThe sources, who requested anonymity as these discussions are confidential, cautioned that Benchling's go-public plans were subject to market conditions and could change. Benchling declined to comment.\nFounded in 2012 by Massachusetts Institute of Technology classmates Sajith Wickramasekara and Ashu Singhal, Benchling has emerged as a prominent player in a niche and growing market for digitizing the R&D process.\nIts valuation has soared since the beginning of 2020, when it was valued at less than $1 billion, as the company benefited from booming R&D investments in pharma and biotech companies. Benchling has so far raised roughly $350 million from venture capital investors including Sequoia Capital and Menlo Ventures.\nBenchling offers customers a variety of software applications and technology platforms, including cloud-based tools and laboratory automation software. Its end-to-end workflow management system allows researchers to collaborate and track projects.\nAccording to its website, over 200,000 scientists currently use Benchling's technology tools. It counts numerous big names from the pharma, life sciences and biotech sectors, including Gilead Sciences , Sanofi, Regeneron, Gingko Bioworks, Zymergen, Lyell Immunopharma Inc and BP's Biosciences Center among its customers.\nEarlier this year, Benchling hired former LinkedIn executive Richard Wong as its chief financial officer as part of its plans to go public.","kind":"news","is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":878765132,"gmtCreate":1637235095733,"gmtModify":1637235095835,"author":{"id":"3581594133816177","authorId":"3581594133816177","name":"OnlyPro","avatar":"https://static.tigerbbs.com/fda79f227cb7358ef6d8e9c9edeaaebe","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3581594133816177","authorIdStr":"3581594133816177"},"htmlText":"[害羞]&nbsp;","listText":"[害羞]&nbsp;","text":"[害羞]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/878765132","repostId":1196614874,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6629299,"gmtCreate":1637237389456,"gmtModify":1637237389546,"authorId":3573474804628073,"author":{"id":3573474804628073,"idStr":"3573474804628073","authorId":3573474804628073,"name":"股神徒孙","avatar":"https://static.tigerbbs.com/ac59f7fc64d3e018af70687bdddf30c2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":878765132,"type":1,"supId":0,"prevId":0,"content":"Okay","text":"Okay","html":"Okay"},{"id":6628999,"gmtCreate":1637235099318,"gmtModify":1637235099408,"authorId":3581594133816177,"author":{"id":3581594133816177,"idStr":"3581594133816177","authorId":3581594133816177,"name":"OnlyPro","avatar":"https://static.tigerbbs.com/fda79f227cb7358ef6d8e9c9edeaaebe","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":878765132,"type":1,"supId":0,"prevId":0,"content":"<u>h</u>","text":"<u>h</u>","html":"<u>h</u>"}],"langContent":"CN"},{"id":878762424,"gmtCreate":1637235057274,"gmtModify":1637235057390,"author":{"id":"3583431682924843","authorId":"3583431682924843","name":"Tinktink","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3583431682924843","authorIdStr":"3583431682924843"},"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878762424","repostId":1196614874,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":878766834,"gmtCreate":1637234948591,"gmtModify":1637234948676,"author":{"id":"3571736667951592","authorId":"3571736667951592","name":"我已经戒赌股票了相信我","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3571736667951592","authorIdStr":"3571736667951592"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878766834","repostId":1196614874,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":878769563,"gmtCreate":1637234352750,"gmtModify":1637234400787,"author":{"id":"3576803907634733","authorId":"3576803907634733","name":"UnknownTD","avatar":"https://static.tigerbbs.com/3b4de5039e388fd6c03e422c40499ee8","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3576803907634733","authorIdStr":"3576803907634733"},"htmlText":"pls like&nbsp;","listText":"pls like&nbsp;","text":"pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878769563","repostId":1196614874,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6628916,"gmtCreate":1637234494878,"gmtModify":1637234494911,"authorId":3581678282566598,"author":{"id":3581678282566598,"idStr":"3581678282566598","authorId":3581678282566598,"name":"granola","avatar":"https://static.tigerbbs.com/794ef04b19a3c79578c403c50a016ac3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":878769563,"type":1,"supId":0,"prevId":0,"content":"Okay!","text":"Okay!","html":"Okay!"}],"langContent":"CN"},{"id":878787839,"gmtCreate":1637234106164,"gmtModify":1637234106263,"author":{"id":"3586941727436981","authorId":"3586941727436981","name":"Syee","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586941727436981","authorIdStr":"3586941727436981"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878787839","repostId":1196614874,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":39,"commentSize":5,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}